Flupenthixol and trifluoperazine: a double-blind investigation in the treatment of schizophrenics.
D002986:Clinical Trials as Topic; D000431:Ethanol / Q000627:therapeutic use; D005116:Extrapyramidal Tracts / Q000187:drug effects; D006801:Humans; D009069:Movement Disorders / Q000139:chemically induced / Q000188:drug therapy; D009483:Neuropsychological Tests; D010879:Piperazines / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011581:Psychological Tests; D012559:Schizophrenia / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000627:therapeutic use*; D014268:Trifluoperazine / Q000009:adverse effects / Q000627:therapeutic use*; D014966:Xanthenes / Q000627:therapeutic use*
D010879:Piperazines; D014149:Tranquilizing Agents; D014966:Xanthenes; D014268:Trifluoperazine; D000431:Ethanol